Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Thoughts on UBX?
-
Illumina Inc. (ILMN $99.96)
- $99.96 P/E (TTM): 12.85X Cap: $15.36B
- View ILMN Profile
- View Questions on ILMN
-
Pacific Biosciences of California Inc. (PACB $1.31)
- $1.31 Cap: $399M
- View PACB Profile
- View Questions on PACB
-
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
-
CRISPR Therapeutics AG (CRSP $51.83)
- $51.83 Cap: $4.71B
- View CRSP Profile
- View Questions on CRSP
-
Opko Health Inc. (OPK $1.38)
- $1.38 Cap: $1.12B
- View OPK Profile
- View Questions on OPK
-
Unity Biotechnology Inc. (UBX)
- Cap: $3M
- View UBX Profile
- View Questions on UBX
-
Intellia Therapeutics Inc. (NTLA $11.36)
- $11.36 Cap: $1.21B
- View NTLA Profile
- View Questions on NTLA
-
ARK Genomic Revolution ETF (ARKG $24.72)
- $24.72 P/E (TTM): 26.8X Cap: $990M
- View ARKG Profile
- View Questions on ARKG
Q: Hi guys. Would you be able to tell me your ratings on these medical stocks for growth and risk please. It would be a 3 year time frame minimum. Thks again for the great job you do.
Q: Thoughts on UBX:US?
Insiders
Share Information
SEC Filings
News and Media